Journal for ImmunoTherapy of Cancer (Nov 2023)

1240 Safety profile of pembrolizumab monotherapy versus pembrolizumab with combined treatments: analysis of french pharmacovigilance database

Laure Thomas,
Samy Babai,
Axelle Histe

Affiliations

Laure Thomas: 4 Regional Pharmacovigilance Center, Henri Mondor Hospital, Créteil, France
Samy Babai: Mondor Hospital, Creteil, France
Axelle Histe: Mondor Hospital, Creteil, France

DOI: https://doi.org/10.1136/jitc-2023-SITC2023.1240
Journal volume & issue: Vol. 11, no. Suppl 1

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal